Notably, the proportion of metabolic high UBE2C+ cancer cells exhibited an increasing trend with the progression of TNM staging and tumor stage ( Figure 2 D and Figure S3B ).
← all excerpts
A Multi-Omics Framework Reveals Tumor Heterogeneity and Predicts Therapeutic Targets in Renal Cell Carcinoma.
1
—
—